Akash Patnaik

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Kiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley, Brian Labadie, Jordan S Shafran, Srikrishnan Rameshbabu, Catherine Drovetsky, Kaela M Bynoe, Solanki Aniruddhsingh, Erica Markiewicz, Xiaobing Fan, Massimo Loda, Akash Patnaik
Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kiranj Chaudagar, Hanna M Hieromnimon, Rimpi Khurana, Brian Labadie, Taghreed Hirz, Shenglin Mei, Raisa Hasan, Jordan S Shafran, Anne Kelley, Eva Apostolov, Ghamdan Al-Eryani, Kate Harvey, Srikrishnan Rameshbabu, Mayme Loyd, Kaela M Bynoe, Catherine Drovetsky, Solanki Aniruddhsingh, Erica Markiewicz, Marta Zamora, Xiaobing Fan, Stephan C Schürer, Alexander Swarbrick, David Brian Sykes, Akash Patnaik
Reversal of lactate and PD-1-mediated macrophage immunosuppression controls growth of PTEN/p53-deficient prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Brian M Olson, Kiranj Chaudagar, Riyue Bao, Sweta Sharma Saha, Christina Hong, Marguerite Li, Srikrishnan Rameshbabu, Raymond Chen, Alison Thomas, Akash Patnaik
BET inhibition sensitizes immunologically-cold Rb-deficient prostate cancer to immune checkpoint blockade. Molecular cancer therapeutics (2023)
Natalie M Reizine, Samantha Socco, Eric Weng, Uka Atueyi, Vikas Mehta, Akash Patnaik
Utilization of Next-Generation Sequencing in Conjunction With Immunohistochemistry to Predict Exceptional Response to Combination Immune Checkpoint Therapy in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer. JCO precision oncology 7 (2023)